Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 05, 2015 7:33 AM ET

Pharmaceuticals

Company Overview of Blue Ash Therapeutics, LLC

Company Overview

Blue Ash Therapeutics, LLC develops Azimilide, an oral once-daily cardiac antiarrhythmic drug. The company was founded in 2008 and is based in Cincinnati, Ohio. As of April 19, 2011, Blue Ash Therapeutics, LLC operates as a subsidiary of Forest Laboratories Holdings Limited.

4555 Lake Forest Drive

Suite 194

Cincinnati, OH 45242

United States

Founded in 2008

Phone:

513-554-0696

Key Executives for Blue Ash Therapeutics, LLC

Co-Founder, Chief Executive Officer, President and Director
Age: 58
Co-Founder, Chief Operating Officer and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
St. Jon Laboratories Inc. United States
Nuron Biotech Inc. United States
LarreaRX Inc. United States
Consolidated Pharmaceutical Group, Inc. United States
TOKU-E Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Blue Ash Therapeutics, LLC, please visit www.blueashtx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.